Drug intelligence / Profile preview

choreito

Development stage: Unknown
Lead developer: Tsumura
Administration: Oral

Overview

Choreito is a traditional Japanese Kampo (herbal) medicine composed of five standardized ingredients: Polyporus sclerotium (Chorei), Poria sclerotium (Bukuryo), Alisma rhizome (Takusha), Talcum (Kasseki), and Donkey-hide glue (Askyo). It is widely used in Japan for the treatment of various urinary tract conditions, including lower urinary tract symptoms (LUTS), bladder pain, and interstitial cystitis. The formula is characterized by its diuretic and anti-inflammatory properties, which help to alleviate micturition pain, residual urine sensation, and hematuria. Tsumura & Co is the primary developer and manufacturer of the standardized extract granules used in clinical practice and research in Japan.

Brand names: Tsumura Choreito Extract Granules
Other names: Zhu Ling TangChorei-to

Beyond the preview

Go deeper on choreito.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on choreito.

Explore the full profile